Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Actinium Pharmaceuticals	Corvus Pharmaceuticals	Cyclerion Therapeutics	Xynomic Pharmaceuticals	Celyad Oncology
Symbol	NYSEAMERICAN:ATNM	NASDAQ:CRVS	NASDAQ:CYCN	OTCMKTS:XYNO	NASDAQ:CYAD
Price Information
Current Price	$8.06	$3.48	$3.84	$2.33	$7.63
52 Week Range	Buy	Buy	N/A	N/A	Buy
MarketRank™
Overall Score	1.5	1.8	0.8	0.3	1.4
Analysis Score	3.5	3.3	0.0	0.0	3.5
Community Score	3.2	2.5	2.5	0.0	2.7
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	3.3	1.7	1.7	0.0
Earnings & Valuation Score	0.6	0.0	0.0	0.0	0.6
Analyst Ratings
Consensus Recommendation	Buy	Buy	N/A	N/A	Buy
Consensus Price Target	$45.00	$8.00	N/A	N/A	$19.00
% Upside from Price Target	458.31% upside	129.89% upside	N/A	N/A	149.02% upside
Trade Information
Market Cap	$109.51 million	$97.66 million	$130.41 million	$115.69 million	$106.38 million
Beta	1.23	1.81	2.2	-1.64	1.69
Average Volume	475,314	1,103,958	960,029	1,033	18,444
Sales & Book Value
Annual Revenue	N/A	N/A	$4.51 million	N/A	$10,000.00
Price / Sales	N/A	N/A	28.92	N/A	10,637.75
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$1.03 per share	$2.42 per share	$3.56 per share	($0.49) per share	$3.67 per share
Price / Book	N/A	N/A	1.08	N/A	2.08
Profitability
Net Income	$-21,900,000.00	$-46,670,000.00	$-123,010,000.00	$-25,100,000.00	$-32,070,000.00
EPS	N/A	($1.59)	N/A	N/A	($2.57)
Trailing P/E Ratio	0.00	N/A	N/A	N/A	N/A
Forward P/E Ratio	N/A	N/A	∞	∞	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	N/A	-2,322.42%	N/A	N/A
Return on Equity (ROE)	-77.96%	-79.15%	-105.55%	N/A	N/A
Return on Assets (ROA)	-64.62%	-63.99%	-57.77%	N/A	N/A
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	N/A	N/A	N/A	0.08%
Current Ratio	10.51%	4.38%	4.31%	N/A	2.73%
Quick Ratio	10.51%	4.38%	4.31%	N/A	N/A
Ownership Information
Institutional Ownership Percentage	17.55%	60.80%	68.17%	N/A	6.39%
Insider Ownership Percentage	1.50%	45.12%	10.70%	86.29%	N/A
Miscellaneous
Employees	30	52	94	27	105
Shares Outstanding	13.59 million	28.06 million	33.96 million	46.27 million	13.94 million
Next Earnings Date	N/A	3/4/2021 (Estimated)	5/3/2021 (Estimated)	6/4/2021 (Estimated)	3/23/2021 (Estimated)
Optionable	Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources